How can we evaluate medication adherence? What are the methods?;Comment évaluer l'adhésion médicamenteuse ? Le point sur les méthodes

Annales Pharmaceutiques Francaises

Volumn 71, Issue 2, 2013, Pages 135-141

  Allenet, B ^a   Baudrant, M ^a   Lehmann, A ^b   Gauchet, A ^c   Roustit, M ^b   Bedouch, P ^a   Golay, A ^d  

^a LABORATOIRE TIMC IMAG   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ GRENOBLE ALPES   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Adherence; Compliance; Measure; Medication

Indexed keywords

BIOLOGICAL MARKER;

ANALYTIC METHOD; ARTICLE; BLOOD EXAMINATION; ELECTRONIC MEDICAL RECORD; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PRESCRIPTION; QUESTIONNAIRE; RELIABILITY; SELF REPORT; URINALYSIS;

DATABASES, FACTUAL; DRUG THERAPY; ELECTRONIC HEALTH RECORDS; HUMANS; MEDICATION ADHERENCE; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84877926370     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2012.10.001     Document Type: Article

References (41)

1. Baudrant M., Lehmann A., Allenet B. Penser autrement l'observance médicamenteuse : d'une posture injonctive à une alliance thérapeutique entre le patient et le soignant - concepts et déterminants. Ann Pharm Fr 2012, 70:15-25.
2. Haynes R.B., Taylor D.W., Sackett D.L. Compliance in health care 1979, John Hopkins University Press, Baltimore.
3. Elliot R. Non-adherence to medicines - not solved but solvable. J Health Serv Res Policy 2009, 14:58-61.
4. Cyrulnik B., Duval P.(Dir). Psychanalyse et résilience 2006, Odile Jacob, Paris.
5. Anaut M. La relation de soin dans le cadre de la résilience. Inform Soc 2009, 156(6):70-78.
6. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
7. Di Matteo M.R. Variations in patients' adherence to medical recommendations. A quantitative review of 50 years of research. Med Care 2004, 42:200-209.
8. Liu H., Golin C.E., Miller L.G., et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001, 134:968-977.
9. Reginster J.Y., Rabenda V. Observance et persistance : impact sur l'efficience des traitements de l'ostéoporose. Rev Med Suisse 2005, 35.
10. Cortet B., Bénichou O. Adhérence, observance, persistance, concordance : prenons-nous en charge correctement nos patients ostéoporotiques ?. Rev Rhum 2006, 73:1-9.
11. Steiner J.F., Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity and applications. J Clin Epidemiol 1997, 50:105-116.
12. Steiner J.F., Koepsell T.D., Fihn S.D., et al. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988, 26:814-823.
13. Vink N.M., Klungel O.H., Stolk R.P., et al. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf 2008, 18(2):159-165.
14. Lo Re V., Amorosa V.K., Localio A.R., et al. Adherence to hepatitis C virus therapy and early virologic outcomes. Clin Infect Dis 2009, 48(2):186-193.
15. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999, 21:1074-1090.
16. Wagner G.J., Rabkin J.G. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?. AIDS Care 2000, 12:405-408.
17. Berg K.M., Arnsten J.H. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 2006, 43(Suppl. 1):S79-S87.
18. Smith M.C., Wertheimer A.I. Social and behavioral aspects of pharmaceutical care 1996, Pharmaceutical Products Press, New York, p. 327-339.
19. Horne R., Weinman J. Concordance, adherence and compliance in medicine taking 2006, NCCSDO, London.
20. Reach G. Clinique de l'observance : l'exemple des diabètes 2006, John Libbey Eurotext, Paris.
21. Myers L.B., Midence K. Concepts and issues in adherence. Adherence to treatment in medical conditions 1998, 8-9. Harwood Academic Publishers, Amsterdam. L.B. Myers, K. Midence (Eds.).
22. Muzenberger N., Souville M., Morin M., et al. Approche biopsychosociale de l'observance thérapeutique et de l'adhérence aux essais cliniques chez les patients infectés par le VIH 1996 1996, ANRS, Paris.
23. Rachid A. Do patients cash prescriptions?. BMJ 1982, 284:24-26.
24. Beardon P.H.G., McGilchrist M.M., McKendrick, et al. Primary non-compliance with prescribed medication in primary care. BMJ 1993, 307:846-848.
25. Robinson A. Improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008, 27(Suppl. 1):9-14.
26. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009, 119:3028-3035.
27. Andrade S.E., Kahler K.H., Frech F., Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15:565-574.
28. Hess L.M., Raebel M.A., Conne D.A., Malone D.C. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006, 40:1280-1288.
29. Allenet B., Sailly J.C. La mesure du bénéfice en santé par la méthode du consentement à payer. J Eco Med 1999, 17(5):301-326.
30. Burnier M., Schneider M.P., Chioleóro A., et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertension 2001, 19(2):335-341.
31. Jay M.S., Durant R.H., Shoffitt T., et al. Effect of peer counselors on adolescent compliance in use of oral contraceptives. Pediatrics 1984, 73:126-131.
32. Choo P.W., Rand C.S., Invi T.S., et al. Validation of patients reports, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999, 37:846-857.
33. National collaborating centre for primary care. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: NICE; 2009.
34. Garfield S., Clifford S., Eliasson L., Barber N., Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 2011, 11:149.
35. Girerd X., Hanon O., Anagnostopoulos K., Ciupek C., Mourad J.J., et al. évaluation de l'observance du traitement anti-hypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé. Presse Med 2001, 30:1044-1048.
36. Macintyre C.R., Goebel K., Brown G.V. Patient knows best: blinded assessment of non-adherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels. Prev Med 2005, 40:41-45.
37. Woldu H., Porta G., Goldstein T., Sakolsky D., Perel J., Emslie G., et al. Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. Am Acad Child Adolesc Psychiatry 2011, 50(5):490-498.
38. Kane S., Becker B., Harmsen W.S., Kurian A., Morisky D.E., Zinsmeister A.R. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease. Am J Gastroenterol 2012, 107(2):154-160.
39. Shi L., Liu J., Fonseca V., Walker P., Kalsekar A., Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes 2010, 8:99.
40. Shi L., Koleva Y., Fonseca V., Kalsekar A., Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010, 28:1097-1107.
41. Garber M.C., Nau D.P., Erickson S.R., Aikens J.E., Lawrence J.B. The concordance of self-report with other measures of medication adherence: a summary of the literature. Medical Care 2004, 42:649-652.